Inflammation correlates with PROs in early RA

In the early phases inflammatory variables directly correlate with the PGA across different disease activity states INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that affects a person’s joints, and may cause pain and disability. Rheumatoid arthritis can affect people of all ages, but it most often starts between the ages of 40 and 60. […]

Read More…

New QIs help assess and improve care in Lupus

Quality indicators can help clinics to implement the EULAR recommendations in everyday care INTRODUCTION Systemic lupus erythematosus (often called Lupus or SLE) is an autoimmune disease. It typically starts in women between the ages of 15 and 45. Lupus symptoms can vary from patient to patient. People with Lupus are often very tired, have joint […]

Read More…

Warfarin users more likely to need joint replacement

Warfarin is associated with greater risk of osteoarthritis than other types of anticoagulant. INTRODUCTION Osteoarthritis is a common condition that makes a person’s joints painful. Some people also experience stiffness when seated for a prolonged period of time. Osteoarthritis is caused by breakdown of the cartilage and changes in the bones as well as other […]

Read More…

Increased COVID-19 risk in autoimmune disease, but not more severe

People with autoimmune disease have an increased risk of getting infected with COVID-19, especially if they use steroid medicines. However, the risk of severe outcomes of COVID-19 such as hospitalisation or death is not increased. INTRODUCTION COVID-19 is the disease caused by a new type of coronavirus called severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). It […]

Read More…

People can regain remission after relapse with rituximab plus steroids

Rituximab plus steroids are useful for putting people back into remission after a relapse of their AAV. INTRODUCTION ANCA-associated vasculitis (shortened to AAV), is a rare group of diseases of the immune system. These diseases are linked to a type of autoantibody called ANCA. An antibody is a protein that the normal healthy immune system […]

Read More…

Vaccination for people with AIIRD

This is the lay version of the EULAR recommendations for vaccination in adults with autoimmune inflammatory rheumatic diseases (often shortened to AIIRD). The original publication can be downloaded from the EULAR website: www.eular.org. Furer V, et al. 2019 Update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 2020 […]

Read More…

Family link between autoimmune disease and congenital heart block

Increased risk of autoimmune disease in people with congenital heart block is shared by their siblings. Introduction Complete congenital heart block without an associated malformation of the heart is a rare condition, affecting only 1 in every 23,000 births in the general population. People with congenital heart block are more likely to get cardiovascular diseases, […]

Read More…

Cellular therapies offer hope in autoimmune disease

The ideal treatment for autoimmunity would be one that can induce self-tolerance before damage has occurred. Introduction Autoimmune disease occurs when a person’s immune system attacks itself, the body’s own cells and tissues. There are many different types of autoimmune disease that can happen as a result –including rheumatoid arthritis or diabetes. At the moment, […]

Read More…

Women’s health in lupus and APS

This is the lay version of the EULAR recommendations for the management of women’s health and family planning in women with lupus and/or antiphospholipid syndrome. The original publication details the recommendations on use of medications, clinical focus points and treatment options. It can be downloaded from the EULAR website: www.eular.org. Andreoli L, et al. EULAR […]

Read More…

Familial Mediterranean fever

This is the lay version of the EULAR recommendations for people with familial Mediterranean fever. The original publication can be downloaded from the EULAR website: www.eular.org. Ozen S, et al. EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis 2016; 75:644–651. doi:10.1136/annrheumdis-2015-208690 Introduction Recommendations give advice to doctors and patients about the […]

Read More…